MTOR and metabolic dysfunction-associated steatotic liver disease: In addition, mTORC1 has been studied for a long time as a possible target to control lipid homeostasis in the liver, but to the best of our knowledge, its role is still unclear, and several studies show conflicting results regarding the role of mTOR in NAFLD [55].